RNASE1 and Disseminated intravascular coagulation: Future studies will tell whether RNase1-based therapies may allow to tackle other cases of chronic neuroinflammation, disseminated intravascular coagulation, or even long-Covid syndrome as a scenario of “runaway inflammation”.